Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

January 13, 2021

LONDON–Covington advised Sensyne Health plc, a UK clinical artificial intelligence company listed on the London AIM market, on its £27.5 million equity fundraising. The fundraise consisted of a placing with institutional investors, a subscription by directors and senior management, and an open offer to the company's existing shareholders. Covington also advised ...

January 6, 2021, Commercial Dispute Resolution

Louise Freeman spoke with Commercial Dispute Resolution about the UK Supreme Court’s judgment in Mastercard v. Merricks, a decision with implications for the country’s class actions regime. Ms. Freeman says that the decision “breathes new life into the class action regime, under which no classes have been certified since it was introduced in 2015.” The ...

January 6, 2021, MedTech Insight

Scott Danzis is quoted in MedTech Insight regarding the FDA’s final guidance on its new Safer Technologies Program for Medical Devices (STeP) program, which is intended to provide additional support to developers of medical devices that significantly improve on existing products. Mr. Danzis says that STeP is a "welcome complement" to the FDA's Breakthrough ...

January 5, 2021, Law.com International

Louise Nash is quoted in Law.com International regarding the key life sciences and technology legal developments she expects to see in 2021. Ms. Nash senses there will be “high levels of activity across all areas, but particularly in life sciences and technology, which have generated a lot of corporate and regulatory work.” She adds, “Life sciences and ...

January 4, 2021, Bloomberg Law

Micaela McMurrough is quoted in Bloomberg Law regarding a new law setting cybersecurity standards for Internet of Things devices that federal agencies buy. Ms. McMurrough says “The statute leverages the purchasing power of the federal government to raise the floor on IoT device cybersecurity.”